DRUG · Unmapped registry intervention
AZD3759
Find medicine records ·
Find other trials using this name
Clinical trial
Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759
NCT03360929
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
AZD3759DRUG
Sponsors & collaborators
LYZZ Alpha Holding Ltdlead sponsor
Tigermed Consulting Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03360929 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.